Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
579 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06748001 | Avapritinib Rollover Study | recruiting | Phase 4 | 60 | Blueprint Medicines CorporationINDUSTRY | 6 | Feb 9, 2026 | clinicaltrials |
| NCT06127407 | Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen(CHONQUER) | recruiting | Phase 3 | 136 | Servier Bio-Innovation LLCINDUSTRY | 17 | Feb 6, 2026 |
| NCT06739655 | Preoperative Radiation Therapy and Immediate Breast Reconstruction(PRADAIIBE) | recruiting | N/A | 180 | Cancer Research AntwerpOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06697197 | A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 413 | Bristol-Myers SquibbINDUSTRY | 9 | Feb 3, 2026 | clinicaltrials |
| NCT07384897 | Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease(IMMUNOPUMON2) | recruiting | N/A | 425 | Université Catholique de LouvainOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT06925984 | Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast) | recruiting | N/A | 48 | Jules Bordet InstituteOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT06840119 | Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers | recruiting | Phase 1 / Phase 2 | 600 | Immunocore LtdINDUSTRY | 6 | Jan 28, 2026 | clinicaltrials |
| NCT07373782 | Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer | recruiting | Phase 2 / Phase 3 | 53 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07370597 | LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.(LUDOPATH) | recruiting | — | 110 | Jules Bordet InstituteOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT05855200 | Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer | recruiting | Phase 3 | 892 | GlaxoSmithKlineINDUSTRY | 28 | Jan 23, 2026 | clinicaltrials |
| NCT06914245 | Personalized Care Pathways for Bowel Symptoms in Rectal Cancer Patients_contributing Factors (Treatable)(Treatable) | recruiting | N/A | 150 | KU LeuvenOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT07146074 | Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases(HERMES) | recruiting | N/A | 120 | Cancer Research AntwerpOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT06406803 | The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients(DIRECT) | recruiting | N/A | 45 | Maastricht University Medical CenterOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT06712459 | Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma | recruiting | — | 100 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 7 | Jan 16, 2026 | clinicaltrials |
| NCT04220970 | Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry | recruiting | — | 150 | The Lymphoma Academic Research OrganisationOTHER | 2 | Jan 14, 2026 | clinicaltrials |
| NCT07339904 | ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectum Surgery in Patients Undergoing Upfront Surgery or Different Neo-adjuvant Treatment Regimens(ProLARS) | recruiting | N/A | 100 | University Hospital, AntwerpOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT07341815 | Parental Support Intervention in an Advanced Oncological Context | recruiting | N/A | 120 | Université Libre de BruxellesOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT07334301 | A Multi-Arm, Platform Trial For Relapsed Neuroblastoma(BEACON2) | recruiting | Phase 1 / Phase 2 | 160 | University of BirminghamOTHER | 5 | Jan 12, 2026 | clinicaltrials |
| NCT05270096 | International Leukemia Target Board(iLTB) | recruiting | — | 600 | Princess Maxima Center for Pediatric OncologyOTHER | 7 | Jan 9, 2026 | clinicaltrials |
| NCT07328178 | Analysis of the Role of IgE Proteoforms in Health and Disease(IgE-PhD) | recruiting | — | 200 | KU LeuvenOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT07323966 | Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients(MASKLESS) | recruiting | N/A | 20 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT04109131 | A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours(BrainStorm) | recruiting | N/A | 600 | Jules Bordet InstituteOTHER | 3 | Jan 6, 2026 | clinicaltrials |
| NCT07315633 | An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer | recruiting | — | 80 | University Hospital, GhentOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT06690775 | CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. | recruiting | Phase 2 | 230 | TORL Biotherapeutics, LLCINDUSTRY | 12 | Dec 23, 2025 | clinicaltrials |
| NCT06934538 | First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer | recruiting | Phase 1 / Phase 2 | 90 | Brenus PharmaINDUSTRY | 3 | Dec 22, 2025 | clinicaltrials |
| NCT06962137 | Phase II RAINSPOT: Zolbetuximab-Paclitaxel-Ramucirumab for CLDN18.2 Positive Gastro-esophageal Cancer(RAINSPOT) | recruiting | Phase 2 | 100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT05259605 | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | recruiting | — | 1,650 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Dec 17, 2025 | clinicaltrials |
| NCT05856981 | Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors | recruiting | Phase 1 | 130 | Sairopa B.V.INDUSTRY | 3 | Dec 17, 2025 | clinicaltrials |
| NCT06717919 | HOPE Against Cancer Recurrence in HCC(HOPE4Cancer) | recruiting | Phase 4 | 220 | Philipp DutkowskiOTHER | 17 | Dec 16, 2025 | clinicaltrials |
| NCT03828773 | PTX3-targeted Antifungal Prophylaxis(PTX3AML) | recruiting | N/A | 410 | Bochud Pierre-YvesOTHER | 3 | Dec 9, 2025 | clinicaltrials |
| NCT06353906 | Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer(PRIAM) | recruiting | Phase 2 | 27 | The Netherlands Cancer InstituteOTHER | 2 | Dec 8, 2025 | clinicaltrials |
| NCT06237803 | European Myeloma Network (EMN) Sample Project(EMN36) | recruiting | — | 6,000 | European Myeloma Network B.V.NETWORK | 10 | Dec 3, 2025 | clinicaltrials |
| NCT04842162 | Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery(MAGNOLIA) | recruiting | Phase 2 | 65 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 2 | Nov 26, 2025 | clinicaltrials |
| NCT06146231 | Motiva Flora® Aesthetic Breast Recon® Clinical Study | recruiting | N/A | 66 | Establishment LabsINDUSTRY | 4 | Nov 26, 2025 | clinicaltrials |
| NCT06193356 | Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable(SCAR) | recruiting | N/A | 141 | University Hospital, GhentOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT07236021 | e-Motion : Promoting Emotion Regulation in Chronic Cancer | recruiting | N/A | 30 | Université Libre de BruxellesOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT06057766 | Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer(LucaMove) | recruiting | N/A | 90 | University Hospital, GhentOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06174987 | A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s) | recruiting | Phase 3 | 50 | Daiichi SankyoINDUSTRY | 12 | Oct 15, 2025 | clinicaltrials |
| NCT04954599 | Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI | recruiting | Phase 1 / Phase 2 | 126 | Maastricht University Medical CenterOTHER | 3 | Oct 7, 2025 | clinicaltrials |
| NCT05841563 | Clinical Trial of PM54 in Advanced Solid Tumors Patients. | recruiting | Phase 1 | 125 | PharmaMarINDUSTRY | 3 | Sep 24, 2025 | clinicaltrials |
| NCT04064359 | Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors | recruiting | Phase 1 | 200 | Oxford BioTherapeutics LtdINDUSTRY | 5 | Sep 16, 2025 | clinicaltrials |
| NCT05658640 | HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies(HEM-iSMART D) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 15 | Sep 16, 2025 | clinicaltrials |
| NCT05745714 | HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART C) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT05751044 | HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART B) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT06780423 | Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients(CTLm-CCP) | recruiting | — | 60 | Hasselt UniversityOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07080476 | Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.(KiTaLymph) | recruiting | N/A | 128 | Universiteit AntwerpenOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06784791 | Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)(NEOpredict-EGF) | recruiting | Phase 2 | 20 | University Hospital, EssenOTHER | 3 | Aug 29, 2025 | clinicaltrials |
| NCT07142096 | WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer(WinQ) | recruiting | N/A | 20 | Université Catholique de LouvainOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT07136844 | Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology(Acti-Adult) | recruiting | N/A | 300 | Centre Hospitalier Universitaire de LiegeOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07075016 | Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy(EVOLVE 1) | recruiting | Phase 3 | 227 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 16 | Aug 19, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials